|
000
| 02699cam 2200469zi 4500 |
|---|
| 001 | 9.933855 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240628092555 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 240213t20242024onca o f000 0 eng d |
|---|
| 020 | |a9780660702445 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-579/2024E-PDF |
|---|
| 245 | 00|aPost-evaluation of stigma and opioid harm reduction advertising campaign (ACET) : |bmethodological report / |cprepared for Health Canada. |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (34 pages) : |billustrations + |e1 executive summary (3 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"March 2024." |
|---|
| 500 | |a"Supplier name: Ipsos Public Affairs." |
|---|
| 500 | |a"Contract Number: CW2338465." |
|---|
| 500 | |a"Registration number: POR 090-23." |
|---|
| 500 | |aIssued also in French under title: Évaluation post-campagne de la campagne publicitaire sur la réduction de la stigmatisation et des méfaits liés aux opioïdes (OECP) : rapport méthodologique. |
|---|
| 520 | |a"In an effort to target and create messaging that resonates with men in physically demanding jobs, a creative concept with a visual identity has been developed as part of Health Canada's multi-year marketing campaign to address the growing opioid overdose crisis"--Page 1. |
|---|
| 650 | 0|aOpioid abuse|zCanada|xPrevention|xPublic opinion. |
|---|
| 650 | 0|aStigma (Social psychology)|zCanada|xPublic opinion. |
|---|
| 650 | 0|aAdvertising campaigns|zCanada|xPublic opinion. |
|---|
| 650 | 0|aGovernment advertising|zCanada|xPublic opinion. |
|---|
| 650 | 0|aPublic opinion|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 710 | 2 |aIpsos (Firm). |bPublic Affairs, |econsultant. |
|---|
| 775 | 08|tÉvaluation post-campagne de la campagne publicitaire sur la réduction de la stigmatisation et des méfaits liés aux opioïdes (OECP) : |w(CaOODSP)9.933857 |
|---|
| 856 | 40|qPDF|s1.04 MB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-579-2024-eng.pdf|zMethodological report |
|---|
| 856 | 40|qPDF|s383 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-579-2024-1-eng.pdf|zExecutive summary |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2024/090-23-e/090-23_report.html|zMethodological report |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2024/090-23-e/summary/090-23_summary.html|zExecutive summary |
|---|